InvestorPlace - Stock Market News, Stock Advice & Trading Tips
NRSN stock results show that NeuroSense Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
The post NRSN Stock Earnings: NeuroSense Therapeutics Misses EPS for Q1 2024 appeared first on InvestorPlace.
More From InvestorPlace